Lowell Thomas Holden, CFO at Nascent Biotech Inc. (NBIO), bought 17,500 shares at $0.14 ($2K) on 2019-10-03, disclosed to the SEC on 2019-10-07.
Open-market purchase of $2k NBIO by CFO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.13 | 7,500 | $975 | 41.1% |
| 2 | $0.14 | 10,000 | $1K | 58.9% |
| Total | $0.14 avg | 17,500 | $2K | 100% |
| Filing → |
| NBIO | BUY | 2023-02-02 | $3K | — | Filing → |
| NBIO | SELL | 2022-07-25 | $1K | — | Filing → |
| SKKY | BUY | 2022-04-11 | $2K | — | Filing → |